Castle Biosciences (CSTL) PT Lowered to $35 at KeyBanc May 29, 2026 10:34AM
KeyBanc Reiterates Overweight Rating on Castle Biosciences (CSTL) as 'TissueCypher Gains Momentum' May 6, 2025 08:22AM
Castle Biosciences to Participate in Upcoming Investor Conferences Feb 25, 2025 04:30PM
Castle Biosciences (CSTL) PT Raised to $36 at KeyBanc Nov 5, 2024 11:49AM
Castle Biosciences to Present at the KeyBanc Capital Markets Virtual Life Sciences & MedTech Investor Forum Mar 12, 2024 07:00AM


Mar 14, 2023 07:00AM Castle Biosciences to Present at the KeyBanc Capital Markets Virtual Life Sciences & MedTech Investor Forum
Mar 1, 2022 07:00AM Castle Biosciences to Present at Upcoming Investor Conferences
Feb 2, 2021 06:54AM Companies with NDRs 2/02